Mississippi legislation · 2026 Regular Session
Mississippi HB1667: Prescription drugs; require that value of manufacturer copay assistance be applied to reduce patient deductible/out-of-pocket maximum costs.
Status: Failed, February 3, 2026
AN ACT TO REQUIRE THAT HEALTH BENEFIT PLANS AND PRESCRIPTION DRUG PROGRAMS THAT PROVIDE COVERAGE FOR PRESCRIPTION DRUGS AND RECEIVE MANUFACTURER COPAY ASSISTANCE FOR A PRESCRIPTION DRUG MUST APPLY THE VALUE OF THE COPAY ASSISTANCE TO REDUCE OR LIMIT THE AMOUNT THAT A PATIENT PAYS FOR A PRESCRIPTION DRUG AND/OR APPLY THE VALUE OF SUCH ASSISTANCE TO A PATIENT'S ANNUAL COST-SHARING REQUIREMENTS, SUCH AS DEDUCTIBLES AND OUT-OF-POCKET MAXIMUM COSTS; TO BRING FORWARD SECTIONS 83-9-5 AND 83-9-6.1, MISSISSIPPI CODE OF 1972, WHICH RELATE TO ACCIDENT AND HEALTH INSURANCE, FOR THE PURPOSES OF POSSIBLE AMENDMENT; AND FOR RELATED PURPOSES.
What the bill says
An act to require that health benefit plans and prescription drug programs that provide coverage for prescription drugs and receive manufacturer copay assistance for a prescription drug must apply the value of the copay assistance to reduce or limit the amount that a patient pays for a prescription drug and/or apply the value of such assistance to a patient's annual cost-sharing requirements, such as deductibles and out-of-pocket maximum costs…
From the introduced text:
AN ACT TO REQUIRE THAT HEALTH BENEFIT PLANS AND PRESCRIPTION DRUG PROGRAMS THAT PROVIDE COVERAGE FOR PRESCRIPTION DRUGS AND RECEIVE MANUFACTURER COPAY ASSISTANCE FOR A PRESCRIPTION DRUG MUST APPLY THE VALUE OF THE COPAY ASSISTANCE TO REDUCE OR LIMIT THE AMOUNT THAT A PATIENT PAYS FOR A PRESCRIPTION DRUG AND/OR APPLY THE VALUE OF SUCH ASSISTANCE TO A PATIENT'S ANNUAL COST-SHARING REQUIREMENTS, SUCH AS DEDUCTIBLES AND OUT-OF-POCKET MAXIMUM COSTS; TO BRING FORWARD SECTIONS 83-9-5 AND 83-9-6.1, MISSISSIPPI CODE OF 1972, WHICH RELATE TO ACCIDENT AND HEALTH INSURANCE, FOR THE PURPOSES OF POSSIBLE AMENDMENT; AND FOR RELATED PURPOSES. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI: SECTION 1. Every health benefit plan or prescription drug program that provides coverage for prescription drugs and receives manufacturer copay assistance for a prescription drug must apply the value of the copay assistance to reduce or limit the amount that a patient pays for such a prescription drug and/or apply the value of such assistance to a patient's annual cost-sharing requirements, such as deductibles and out-of-pocket maximum costs. SECTION 2. Section 83-9-5, Mississippi Code of 1972, is brought forward as follows: 83-9-5. (1) Required provisions. Except as provided in subsection (3) of this section, each such policy delivered or *HR43/R1568* H. B. No. 1667 ~ OFFICIAL ~ G1/2 26/HR43/R1568 PAGE 1 (RKM\KP) …
Sponsors
- Tullos, Mark (R, 79) · primary sponsor
Latest actions
- : Died In Committee
- : Referred To State Affairs
Subjects: Prescription drugs
Common questions
- What is HB1667?
- HB1667 is a bill in the Mississippi Legislature (2026 Regular Session): Prescription drugs; require that value of manufacturer copay assistance be applied to reduce patient deductible/out-of-pocket maximum costs.
- What does HB1667 do?
- In its own words: An act to require that health benefit plans and prescription drug programs that provide coverage for prescription drugs and receive manufacturer copay assistance for a prescription drug must apply the value of the copay assistance to reduce or limit the amount that a patient pays for a prescription drug and/or apply the value of such assistance to a patient's annual cost-sharing requirements, such as deductibles and out-of-pocket maximum costs…
- What is the status of HB1667?
- Failed as of February 3, 2026. Latest action: Died In Committee (February 3, 2026).
- Who sponsored HB1667?
- Tullos, Mark (R, 79).
- Where is the official record for HB1667?
- On the Mississippi Legislature website: http://billstatus.ls.state.ms.us/2026/pdf/history/HB/HB1667.xml
Source: official Mississippi record. Tracked by Delilah, AI for legislation across all 50 states and Congress.